Cordova Ashley - Oct 31, 2023 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role
Chief Financial Officer
Signature
Ovie Onobrakpeya, as attorney in fact for Cordova, Ashley
Stock symbol
NVCR
Transactions as of
Oct 31, 2023
Transactions value $
$172,453
Form type
4
Date filed
11/2/2023, 04:20 PM
Previous filing
Sep 5, 2023
Next filing
Feb 29, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCR Ordinary Shares Options Exercise $86.6K +7.56K +7.59% $11.46 107K Oct 31, 2023 Direct
transaction NVCR Ordinary Shares Options Exercise $28.4K +2.48K +2.31% $11.44 110K Oct 31, 2023 Direct
transaction NVCR Ordinary Shares Options Exercise $55.4K +7.75K +7.07% $7.15 117K Oct 31, 2023 Direct
transaction NVCR Ordinary Shares Options Exercise $2.01K +175 +0.15% $11.46 118K Nov 2, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVCR Stock Option (Right to Buy) Options Exercise $0 -7.56K -97.74% $0.00 175 Oct 31, 2023 Ordinary Shares 7.56K $11.46 Direct F1
transaction NVCR Stock Option (Right to Buy) Options Exercise $0 -2.48K -100% $0.00* 0 Oct 31, 2023 Ordinary Shares 2.48K $11.44 Direct
transaction NVCR Stock Option (Right to Buy) Options Exercise $0 -7.75K -100% $0.00* 0 Oct 31, 2023 Ordinary Shares 7.75K $7.15 Direct F2
transaction NVCR Stock Option (Right to Buy) Options Exercise $0 -175 -100% $0.00* 0 Nov 2, 2023 Ordinary Shares 175 $11.46 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vests 2,686 share(s) on 24-Feb-2019, 6,250 share(s) on 24-Feb-2020
F2 Vests 2 share(s) on 22-Feb-2018, 9,750 share(s) on 22-Feb-2021